CPHRF News and Press, Companhia Siderurgica Paulista Nova Cosipa

Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders Canada NewsWire MISSISSAUGA, ON , June 14, 2024 /CNW/ - Cipher Pharmaceuticals Inc . (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the "Company ") today announced that i...

2024-05-10 10:06:09 ET Cipher Pharmaceuticals Inc. (CPHRF) Q1 2024 Earnings Conference Call May 10, 2024 08:30 A.M. ET Company Participants Craig J. Mull - Interim CEO Bryan Jacobs - CFO Conference Call Participants André Uddin - Research Capital ...

2024-05-09 17:56:08 ET More on Cipher Pharmaceuticals Cipher Pharmaceuticals Inc. (CPHRF) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Cipher Pharmaceuticals Read the full article on Seeking Alpha For further details see: Cipher...

Cipher Pharmaceuticals Reports First Quarter 2024 Results Canada NewsWire (All figures are presented in U.S. Dollars) Adjusted EBITDA in Q1 2024 was $3.6 million , an increase of 12.5% over Q1 2023 Epuris sales volumes grew 7.2% in the quarter over Q1 2023, c...

Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON , May 3, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will release ...

Mississauga, Ontario--(Newsfile Corp. - April 3, 2024) - Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre .   CEO Cr...

2024-03-15 10:33:04 ET Cipher Pharmaceuticals Inc. (CPHRF) Q4 2023 Earnings Conference Call March 15, 2024 8:30 am ET Company Participants Craig Mull - Chief Executive Officer (interim) Bryan Jacobs - Chief Financial Officer Conference Call Participants A...

2024-03-14 17:42:21 ET More on Cipher Pharmaceuticals Seeking Alpha’s Quant Rating on Cipher Pharmaceuticals Historical earnings data for Cipher Pharmaceuticals Financial information for Cipher Pharmaceuticals Read the full article on Seeking Alpha ...

Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results Canada NewsWire (All figures are presented in U.S. Dollars) Cash at December 31, 2023 was $39.8 million ( CDN$52.7 million ) or $1.66 per outstanding common share (CDN$2.20) ...

Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON , March 8, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will releas...